Printer Friendly

Maternal bisphenol A exposure and experimental asthma in mouse pups.

It has been proposed that the increasing prevalence of childhood asthma in developing countries may be related to immunologic effects of environmental contaminants, including exposure to environmental estrogens recently shown to induce mast cell degranulation and enhance allergic responses in animal models. Midoro-Horiuti et al. (p. 273) evaluated airway hyperresponsiveness (AHR) in the offspring of female BALB/c mice that received 10 [micro]g/mL bisphenol A (BPA; a dose designed to produce body burdens similar to those of humans) in their drinking water from 1 week before conception through pregnancy and lactation. A subset of pups was also exposed to ovalbumin (OVA) at a dose below that normally required to cause allergic sensitization. The authors report that OVA-sensitized pups born to BPA-treated mothers had increased numbers of eosinophils in broncho alveolar lavage fluid, increased airway responsiveness (based on whole-body barometric plethysmography following a methacholine challenge), and higher anti-OVA serum IgE concentrations than pups born to BPA-unexposed mothers. The authors conclude that perinatal exposure to BPA enhanced allergic sensitization and bronchial inflammation and responsiveness in their animal model of asthma, but note that additional research is needed to determine cellular and molecular mechanisms for these effects.

COPYRIGHT 2010 National Institute of Environmental Health Sciences
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research
Publication:Environmental Health Perspectives
Article Type:Brief article
Date:Feb 1, 2010
Words:196
Previous Article:Computational steroidogenesis model.
Next Article:U.S. population exposure to acrylamide (NHANES 2003-2004).
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |